China Blood Glucose Monitor Market (2025-2030)
The China Blood Glucose Monitor Market was valued at $304.1 Million in 2025 and projected to reach to $515.7 Million by 2030, representing a compound annual growth rate of 11.1%. China's blood glucose monitor market is positioned for sustained growth, expanding from USD 304.1 million in 2025 to USD 515.7 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Blood Glucose Monitor Market Trends and Insights
- This 11.1% compound annual growth rate reflects China's rising diabetes prevalence, increasing healthcare spending, and growing adoption of continuous glucose monitoring (CGM) technologies.
- China's aging population and urbanization trends are driving demand for convenient, accurate glucose monitoring solutions across both urban and rural regions. The Chinese market benefits from strong government support for diabetes management initiatives and expanding insurance coverage for glucose monitoring devices.
- China's domestic manufacturers are scaling production capacity while international players establish regional hubs to capture market share.
- Between 2025 and 2030, China is expected to become a critical growth engine within the Asia Pacific blood glucose monitor sector, driven by technological innovation, smartphone integration, and rising consumer awareness of preventive healthcare..
Key Market Statistics
- CAGR (2025-2030) 11.1% CAGR
- Market Size, 2025 ~USD 304.1 Million
- Forecast, 2030 ~USD 515.7 Million
- Country China
China Blood Glucose Monitor Market Overview
Rapid Market Expansion :
China's blood glucose monitor market is growing at 11.1% CAGR, significantly outpacing the global rate of 9.1%, driven by increasing diabetes diagnosis rates and healthcare modernization initiatives across urban and rural regions.
CGM Technology Adoption :
Continuous glucose monitoring technologies are gaining traction in China as patients and healthcare providers recognize superior disease management benefits, with reimbursement policies gradually expanding to support wider adoption.
Aging Population Impact :
China's demographic shift toward an aging society is intensifying demand for blood glucose monitoring solutions, as elderly populations face higher diabetes prevalence and require consistent glucose management.
Urbanization & Healthcare Spending :
Rising urbanization and increased healthcare expenditure in tier-1 and tier-2 cities are creating favorable conditions for premium glucose monitoring devices and digital health integration solutions.
China Blood Glucose Monitor Market Dynamics
- This trajectory is underpinned by China's escalating diabetes epidemic, government healthcare reforms prioritizing chronic disease management, and accelerating adoption of digital health technologies.
- The market benefits from strong domestic manufacturing capabilities and increasing investments in medical device innovation. Key growth catalysts include rising consumer awareness of preventive healthcare, expanding insurance coverage for glucose monitoring devices, and integration with mobile health platforms.
- As China strengthens its healthcare infrastructure and middle-class consumers demand better disease management tools, the market will likely see increased competition from both international and domestic manufacturers, driving innovation and accessibility across all socioeconomic segments..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- China's blood glucose monitor market will grow from USD 304.1M (2025) to USD 515.7M (2030) at an 11.1% CAGR.
- China's rising diabetes prevalence and aging population are primary drivers of sustained market expansion.
- China's domestic manufacturers and international competitors are competing aggressively for market share through innovation and regional distribution.
- China's government support and expanding insurance coverage are accelerating adoption of glucose monitoring devices nationwide.
Blood Glucose Monitor Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | NON-INVASIVE PRODUCTS (Product Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.1% from 2025 to 2030 |
| Largest Segment | DIABETES MANAGEMENT (Application) |
| Market Size Base Year (Billions) | ~USD 16.44 (2025) |
| Revenue Forecast (Billions) | ~USD 25.41 (2030) |
| Segments Covered | Product Type, Type, Test Site, Application, End User |
China Blood Glucose Monitor Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product Type
- Continuous Glucose Monitoring Systems
- Non-Invasive Products
- Professional Point-Of-Care Devices
- Self-Monitoring Blood Glucose Systems
By Type
- Glucometers
- Implants
- Lancets & Lancing Devices
- Sensors
- Testing Strips
- Transmitters & Receivers
- Type 1 Diabetes
- Type 2 Diabetes
By Test Site
- Fingertip
- Other Test Sites
- Upper Arm
By Application
- Diabetes Management
- Health & Wellness Monitoring
- Other Applications
By End User
- Hospitals & Clinics
- Other End Users
- Self/Home Care
CHINA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS & CLINICS | 69.5 | 74.3 | 80 | 85.1 | 92.5 | 99.9 | 108.2 | 117.3 | 8 |
| OTHER END USERS | 41.7 | 45.8 | 50.7 | 55.5 | 62.1 | 69 | 76.9 | 85.8 | 11.1 |
| SELF/HOME CARE | 474.3 | 528.9 | 593.5 | 658.6 | 746.9 | 841.6 | 950.2 | 1075 | 12.6 |
| TOTAL | 585.4 | 649 | 724.3 | 799.2 | 901.5 | 1010.6 | 1135.3 | 1278.1 | 12 |
Target Audience
- Medical Device Manufacturers : Manufacturers need China-specific market data to assess market entry feasibility, competitive positioning, pricing strategies, and regulatory requirements for glucose monitoring devices in this high-growth market.
- Healthcare Investors & PE Firms : Investors require validated market size, growth projections, and China-specific risk assessments to evaluate investment opportunities in glucose monitoring companies, distributors, and digital health platforms.
- Pharmaceutical & Diagnostic Companies : Companies need market intelligence on diabetes management trends, CGM adoption rates, and healthcare spending patterns in China to inform product portfolios and strategic partnerships in glucose monitoring.
- Healthcare Consultants & Advisors : Consultants require detailed China market analysis to advise clients on market entry strategies, competitive positioning, regulatory navigation, and growth opportunities in the blood glucose monitor segment.
- Government & Policy Organizations : Policy makers and health authorities need market data to understand diabetes management trends, device accessibility gaps, and reimbursement policy impacts for informed healthcare planning and regulation.
Key Companies in the China Blood Glucose Monitor Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Long-term acute care hospitals (LTACHs) – drug-intensive episodes,Inpatient rehabilitation facilities (IRFs) – rehab with chronic comorbidities,Contract rehabilitation and ancillary services, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices,Diagnostic Products,Nutritional Products, |
| DEXCOM, INC. | United States | Public Company | Dexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE and ONE+, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring), |
| SINOCARE | China | Public Company | Blood glucose monitoring systems and strips,Blood pressure and multiparameter testing devices,Hospital and primary healthcare diagnostic solutions, |
| I-SENS, INC. | South Korea | Public Company | Blood glucose meters and strips (human),POCT systems (blood gas, electrolytes, coagulation),Veterinary diagnostics, |
| NIPRO | Japan | Public Company | Dialysis products and services,Injection and infusion / hospital disposables,Pharmaceuticals (generics and kits), |
| NEMAURA MEDICAL INC. | United States | Public Company | sugarBEAT non-invasive CGM,proBEAT wellness and coaching programs,Diabetes prevention and reversal services, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, the company operates as a major provider of healthcare services across the nation.
ABBOTT LABORATORIES
Abbott Laboratories is a public company founded in 1888 and based in the United States. With 115,000 employees, it operates as a diversified healthcare and diagnostics company with a global presence.
DEXCOM, INC.
Dexcom, Inc. is a publicly traded company founded in 1999 and headquartered in the United States. The company employs 11,050 people and specializes in continuous glucose monitoring technology.
MEDTRONIC
Medtronic is a public company founded in 1949 and based in Ireland. With 95,000 employees, it is a global leader in medical technology and device manufacturing.
SINOCARE
Sinocare is a publicly traded company founded in 2002 and headquartered in China. The company employs 5,010 people and operates in the healthcare and medical device sector.
I-SENS, INC.
I-SENS, Inc. is a publicly traded company founded in 2000 and based in South Korea. The company employs 887 people and operates in the medical device and diagnostics industry.
NIPRO
Nipro is a publicly traded company founded in 1947 and based in Japan. With 38,593 employees, it manufactures medical devices and pharmaceutical products for global markets.
NEMAURA MEDICAL INC.
Nemaura Medical Inc. is a publicly traded company founded in 2009 and headquartered in the United States. With 36 employees, the company develops wearable medical technology solutions.
TERUMO CORPORATION
Terumo Corporation is a publicly traded company founded in 1921 and based in Japan. With 30,591 employees, it manufactures and distributes medical devices and blood products globally.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation (USD 304.1M in 2025) and verified 11.1% CAGR projections specific to China, enabling accurate financial forecasting and investment decision-making for market entry or expansion strategies.
- Competitive Landscape Intelligence : Understand China-specific competitive dynamics, local manufacturer capabilities, and market share distribution to identify partnership opportunities, competitive positioning, and differentiation strategies in this high-growth market.
- Regulatory & Reimbursement Insights : Access detailed analysis of China's evolving regulatory framework, insurance coverage policies, and government healthcare initiatives affecting glucose monitor adoption and market accessibility across different regions.
- Consumer Behavior & Demand Drivers : Leverage China-specific insights on diabetes prevalence trends, urbanization patterns, aging demographics, and healthcare spending behaviors to tailor product development, marketing, and distribution strategies effectively.
- Technology Adoption Trends : Identify CGM technology penetration rates, digital health integration opportunities, and mobile platform preferences unique to China's market, informing innovation roadmaps and go-to-market strategies.
Frequently asked questions
What is the current size of China's blood glucose monitor market?
China's blood glucose monitor market is valued at USD 304.1 million in 2025 and is projected to grow to USD 515.7 million by 2030.
What is the growth rate of China's blood glucose monitor market?
China's blood glucose monitor market is growing at a compound annual growth rate (CAGR) of 11.1% from 2025 to 2030.
What factors are driving growth in China's blood glucose monitor market?
Key drivers include rising diabetes prevalence, an aging population, increased healthcare spending, government support for diabetes management, expanding insurance coverage, and growing adoption of continuous glucose monitoring technologies.
Who are the main competitors in China's blood glucose monitor market?
China's market includes both domestic manufacturers scaling production capacity and international players establishing regional hubs to compete for market share through innovation and distribution networks.
How is China's blood glucose monitor market expected to evolve by 2030?
By 2030, China is expected to become a critical growth engine within Asia Pacific, driven by technological innovation, smartphone integration, and rising consumer awareness of preventive healthcare solutions.
RESEARCH METHODOLOGY
The study comprised four key activities to estimate the current size of the blood glucose monitor market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step involved validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Top-down and bottom-up approaches were used to arrive at a comprehensive estimate of the overall market size. Finally, market breakdown and data triangulation techniques were utilized to determine the sizes of segments and subsegments within the market.
Secondary Research
The secondary research process involved extensive use of various secondary sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the blood glucose monitor market. It also helped obtain critical insights about key players in the industry, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.
Primary Research
In the primary research process, interviews were conducted with various sources from the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts were interviewed, including CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from prominent companies and organizations involved in the blood glucose monitor market. For the demand side, interviews were conducted with industry experts, purchase and sales managers, doctors, and personnel from research organizations. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents for the blood glucose monitor market is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the blood glucose monitor market includes the following details. The market sizing was undertaken from the global side.
Country-level Analysis: The size of the blood glucose monitor market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall blood glucose monitor market was obtained from secondary data and validated by primary participants to arrive at the total blood glucose monitor market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall blood glucose monitor market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Blood Glucose Monitor Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.
Market Definition
Blood glucose monitors are medical devices used to measure and monitor blood glucose (sugar) levels in individuals, primarily for the diagnosis and management of diabetes mellitus. These monitors help patients and healthcare professionals assess glycemic control, adjust treatment plans, and prevent diabetes-related complications.
Stakeholders
- Blood Glucose Monitor Manufacturers
- Contract Manufacturers
- Suppliers and Distributors of Blood Glucose Monitors
- Senior Management
- Finance Department
- Healthcare Services Providers (Hospitals and Public & Private Clinics)
- Academic & Research Institutes
- E-commerce and Digital Platforms
- Retail Pharmacies and Supermarkets
- Trade Associations and Industry Bodies
- Regulatory Bodies and Government Agencies
- Business Research and Consulting Service Providers
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, segment, analyze, and forecast the global blood glucose monitor market by product type, application, test site, end user, and region.
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the blood glucose monitor market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To profile the key players in the blood glucose monitor market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product approvals & launches in the blood glucose monitor market.
Get the Full Blood Glucose Monitor Market Report
Full forecast, segment splits, and company analysis for all Blood Glucose Monitor Market.
- Canada Blood Glucose Monitor Market
- US Blood Glucose Monitor Market
- Germany Blood Glucose Monitor Market
- UK Blood Glucose Monitor Market
- France Blood Glucose Monitor Market
- Italy Blood Glucose Monitor Market
- Spain Blood Glucose Monitor Market
- Japan Blood Glucose Monitor Market
- India Blood Glucose Monitor Market
- Australia Blood Glucose Monitor Market
- South Korea Blood Glucose Monitor Market
- Brazil Blood Glucose Monitor Market
- Mexico Blood Glucose Monitor Market
- GCC Countries Blood Glucose Monitor Market
- Rest Of Europe Blood Glucose Monitor Market
- Rest Of Asia Pacific Blood Glucose Monitor Market
- Rest Of Latin America Blood Glucose Monitor Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report